In the latest trading session, Amgen (AMGN) closed at $344.55, marking a -1.17% move from the previous day. The stock fell short of the S&P 500, which registered a gain of 0.8% for the day. On the ...

Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

Looking ahead to 2030, our model projects AMGN could trade at an average price of $537.89, with a potential range between $403.41 and $672.36. This represents a potential 57.0% return from today's ...

If you are wondering whether Amgen’s recent share price puts it on sale or at a premium, and what that really means for your ...

Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming ...

Amgen Inc. (NASDAQ:AMGN) is one of Jim Cramer’s Hottest GLP-1 and Weight Loss Stock Picks. Amgen Inc. (NASDAQ:AMGN) is one of the largest drug companies in the world. The firm is currently developing ...

Canaccord Genuity analyst initiated coverage with a Hold rating on Amgen yesterday and set a price target of $366.00. The company’s shares closed yesterday at $344.86. Claim 30% ...

Amgen (AMGN) stock climbs as MariTide GLP-1 trials demonstrate nearly 20% weight loss. Truist raises price target to $325 amid growing optimism.

We recently compiled a list of the 10 Most Undervalued Dow Stocks to Buy Now. Amgen Inc. is one of the most undervalued ...

Investors in Amgen Inc (Symbol: AMGN) saw new options become available today, for the April 24th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AMGN options ...